e-SPACE Heart Failure 2024
Published: 28 October 2024
-
Views:
974
-
Likes:
7
-
Views:
974
-
Likes:
7
-
Up Next -
1h 4m 48sPart 1 | Session 7 Plenary session 5 – Cardiac rhythm in HF
-
1h 13m 18sPart 1 | Session 8 Plenary session 6 – Devices in HF; time to reassess their place?
-
58m 32sPart 2 | Session 1 Plenary session 7 – Enabling GDMT in HF
-
1h 54sPart 2 | Session 2 Plenary session 8 – Iron deficiency: the totality of evidence
-
59m 41sPart 2 | Session 3 Plenary session 9 – Managing HFpEF in 2024
-
1h 45sPart 2 | Session 4 Plenary session 10 – Valvular heart disease
-
59m 47s
-
1h 57sPart 1 | Session 1 Plenary session 1 – Practical implementation of GDMT in the clinical setting Vijay Chopra, Tarek Bekfani, Gianluigi Savarese, Jasper J Brugts, Justin Ezekowitz
-
1h 2m 9sPart 1 | Session 2 Plenary session 2 – SGLT2s in clinical practice John J Atherton, Tarek Bekfani, Javed Butler, Clara Saldarriaga, Faiez Zannad
-
1h 7m 6sPart 1 | Session 3 Special session 1 – Cardiac rhythm management devices: cornerstones of comprehensive, patient-centred HF care The-DIRECT-HF initiative (The DIRECT HF educational programme is supported by Medtronic) Biykem Bozkurt, Javed Butler, Giuseppe Rosano, Gianluigi Savarese, Shelley Zieroth
-
59m 29sPart 1 | Session 4 Plenary session 3 – Obesity and weight management in HF Stefan Anker, Petar M Seferovic, Naveed Sattar, Shelley Zieroth, Shahzeb Khan, Peter Rossing
-
28m 30sPart 1 | Session 5 Special session 2 – Face to face with cardiac amyloidosis Thibaud Damy
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure held on the 18-19 October 2024.
e-SPACE Heart Failure 2024 once again provided top-tier free virtual education and optimised geographical reach whilst delivering both global and regional insight. The thoughtfully curated programme explored how leading experts are incorporating heart failure guidelines into clinical practice and offered the latest information on patient profiling in heart failure for tailored medical therapy.
Building on the tremendous success of previous years, this event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Related sessions to e-SPACE Heart Failure 2024:
- Meet the Experts: SGLT2 Inhibitors in Real Life: Everything the Clinician Needs to Know
- Meet the Experts: GDMT Implementation in HF: How to Tackle Clinical Inertia?
- Meet the Experts: Management of Transthyretin Amyloid Cardiomyopathy (ATTRCM): Optimising Patient Pathways
- Meet the Experts: IV Iron in Clinical Practice: Experts’ Perspectives
- Meet the Experts: Hyperkalemia in HF: Clinical Impact and Long-term Management
- Symposium: SGLT2 Inhibitors in Heart Failure: Updates on Prevention and Treatment
- Meet the Experts: Non-steroidal MRAs: Evolving Role in Heart Failure
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Arnt Kristen
Arnt Kristen practices in Heidelberg, Germany. His top areas of expertise are Primary Amyloidosis, Transthyretin Amyloidosis, Cardiac Amyloidosis, Heart Transplant, and Tissue Biopsy.
Carsten Tschöpe
MD
Dr Tschöpe is Professor of Medicine and Cardiology and the Vice Director of the Department of Cardiology, Charité, Campus Virchow Klinikum, Berlin, guiding the cardiomyopathy programme. His main research interests are the potential of cell therapies to cure heart failure and the role of the immune system in heart failure.
Michelle Kittleson
Cardiologist & Professor of Medicine
Dr Michelle Kittleson is Professor of Medicine at Cedars-Sinai and Director of Education in Heart Failure and Transplantation at the Smidt Heart Institute. She graduated from Harvard College and received her medical degree from Yale University. She completed residency training at Brigham and Women's Hospital and cardiology fellowship at Johns Hopkins, where she also received a PhD in Clinical Investigation.
Dr Kittleson is Interim Editor-in-Chief of the Journal of Heart and Lung Transplantation, on writing committees for the ACC/AHA Hypertrophic Cardiomyopathy Guidelines and the ACC/AHA/HFSA HF Guidelines, Co Editor-in-Chief for the ACC Heart Failure Self-Assessment Program, and on the Board of Directors for the Heart Failure Society of America. Her essays have appeared in the New England Journal of Medicine, Annals of Internal Medicine…
Marianna Fontana
Professor of Cardiology and Honorary Consultant Cardiologist
Prof Marianna Fontana is Professor of Cardiology and Honorary Consultant Cardiologist at the National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
Her main clinical and research interests include the delivery of efficient and effective care for patients with amyloidosis, with a particular focus on new technologies.